ArticleBMJ open2024
Investigating the relationship between opium use and coronary slow flow: a propensity score matched case-control study.
Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesRecent studies have suggested a potential link between opium consumption and microvascular dysfunction in coronary arteries, which may contribute to the development of coronary slow-flow syndrome. This study aims to investigate the relationship between opium use and coronary slow-flow syndrome. DESIGN AND
settingThis retrospective study analysed medical records of patients who underwent coronary angiography at the Tehran Heart Center from 2006 to 2020. It focused on those with coronary slow flow phenomenon (CSFP) or non-obstructive coronary artery disease, excluding patients with significant left ventricular dysfunction (left ventricular ejection fraction <40%), previous coronary revasculariation, arrhythmias or coronary artery ectasia. The coronary slow flow was assessed using thrombolysis in myocardial infarction flow grade and frame count. Propensity score matching and inverse probability weighting were applied to minimise confounding variables. Conditional logistic regression and logistic regression models were then used to examine the association between opium use and coronary slow flow, controlling for potential confounders.
resultsAmong 21 835 patients with normal coronary angiograms, 767 were identified with CSFP and matched with 3068 controls. The mean age of CSFP patients was 51.59 years, with 64.6% male. Opium use was similar, reported in 8.9% of CSFP patients and 9.5% of controls (p=0.96). Within the CSFP group, opium use was associated with more extensive coronary artery involvement (33.3% vs 18.9%, p=0.03). Initial analysis indicated a higher risk for CSFP in opium users (OR: 1.74, p=0.001), but after adjustments, no significant association was found (OR: 1.06, p=0.70; OR: 1.15, p=0.55).
conclusionOur study indicates that opium use is not an independent risk factor for CSFP but may exacerbate the severity of coronary artery involvement, noted by a higher incidence of multivessel disease among users. This suggests that opium may affect the extent of coronary artery issues rather than cause CSFP directly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.